IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharmaceutical Manufacture: Peptide Applications for Cardiovascular Therapies

2:30 PM MST | November 13, 2009 | Gary Hu, American Peptide Company

Gary Hu, American Peptide Company, VP Sales & Marketing A recent report by market and technology research firm Frost & Sullivan projected that the global peptide therapeutics market will be valued at nearly $2 billion by 2010, with Europe contributing more than a third, or $605 million, in a rapid development to meet the increasing need for new therapeutic approaches with peptides as active pharmaceutical ingredients (APIs). The peptide therapeutics market, according to Frost & Sullivan, is providing new commercial opportunities to life science...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa